Inquiry Basket
Loading ......
Detecting neomycin in real-world samples is no small challenge. Neomycin, a widely used aminoglycoside antibiotic, can persist in foods, biological fluids, and environmental samples at trace levels. For researchers, food safety inspectors, and pharmaceutical scientists, understanding the detection limits in these complex matrices is critical—not only for compliance with regulations but also for ensuring consumer safety and reliable pharmacokinetic studies. This article explores the current methods, their sensitivity, and practical considerations for measuring neomycin at ultra-low levels.
Neomycin residues rarely occur in isolation. In food, body fluids, or environmental samples, interfering substances such as proteins, fats, salts, and organic compounds complicate accurate measurement. These matrix effects can mask or distort signals, meaning traditional detection methods may fail to reveal low-level residues. Researchers and practitioners therefore face a dual challenge: maximizing sensitivity while minimizing false positives or interference.
Fortunately, advances in analytical chemistry have significantly lowered detection limits (LOD) for neomycin. The LOD now depends on both the sample type and the method used. Conventional approaches like high-performance liquid chromatography (HPLC) typically achieve µg/kg levels, sufficient for routine regulatory checks. In contrast, emerging techniques—nanomaterial-based sensors, immunoassays, and fluorescence methods—push detection into the nM or even pM range, enabling trace-level monitoring in complex matrices.
Food safety remains one of the most critical arenas for neomycin testing. Regulatory agencies, including the European Union (EU) and Health Canada, set maximum residue limits (MRL) for animal-derived products such as milk, meat, honey, and eggs. Effective detection must achieve sensitivity below these thresholds.
| Method | Sample Type | LOD | Notes |
| Chemiluminescence ELISA | Milk | 9.4 µg/kg | High sensitivity; suitable for rapid screening. |
| Lateral Flow Immunoassay | Pig liver, milk, whole egg | 30 µg/kg (liver); 20 ng/mL (milk) | Visual detection well below MRL; ideal for on-site tests. |
| LC-MS/MS | Honey, meat, tissues | 0.014 mg/kg (14 µg/kg) | Gold-standard confirmatory method with very high precision. |
| Modular Immunoassay Reagents | Honey | 0.014 mg/kg visual; 0.07 µg/mL instrumental | Modular design improves sensitivity and matrix adaptability. |
| Chemiluminescence Immunoassay | Milk | 9.4 µg/kg | High-throughput screening for large sample volumes. |
These results indicate that ELISA and LC-MS/MS remain dominant for regulatory compliance. ELISA allows rapid, cost-effective screening, while LC-MS/MS provides the confirmatory precision required for legal and safety validation.
For pharmacokinetics, toxicology, or environmental monitoring, sensitivity demands often exceed regulatory requirements. The concentration of neomycin in urine, blood, or environmental water may be extremely low, necessitating methods capable of detecting nanomolar or picomolar levels.
| Method | Sample Type | LOD | Notes |
| Electrochemical Sensors (Square Wave Voltammetry) | General solutions | 1.4 × 10⁻¹⁰ M (~0.14 nM) | High sensitivity through current signal amplification. |
| Fluorescence (Polydiacetylene Supramolecules) | General solutions | 2.55 × 10⁻⁷ M (~255 nM) | Rapid, qualitative or semi-quantitative analysis. |
| Resonance Scattering Spectroscopy | Ear drops, urine | 0.03 µg/mL (30 ng/mL) | Suitable for body fluid monitoring via ionic interactions. |
| Capillary Electrophoresis with Indirect Laser-Induced Fluorescence | Fish tissue | Optimized for tissue extraction | Addresses challenges of complex tissue matrices. |
| Colorimetric (Melamine-Modified AuNPs) | Milk | 30 pM | Extremely low LOD; aggregation-based color change enables visual detection. |
These methods illustrate how nanotechnology and advanced sensing can overcome matrix interference, enabling detection at levels far below traditional limits. Colorimetric and electrochemical approaches, in particular, offer practical solutions for trace-level monitoring in both research and applied contexts.
Accurate measurement of neomycin in high-fat or high-protein samples, such as milk, honey, or animal tissues, often requires pre-treatment to remove interfering compounds. Solid-phase extraction (SPE) or immunoaffinity extraction (IAE) are commonly employed to enrich target molecules and improve sensitivity. These steps are essential for achieving nM or pM detection levels in food and biological samples, especially when using fluorescence, electrochemical, or nanomaterial-based sensors.
Selection depends largely on the intended application:
The trend is clear: while traditional methods remain reliable, advanced sensor technologies are rapidly pushing the boundaries of what we can detect in complex matrices.
Detecting neomycin in complex matrices is no longer limited by traditional analytical techniques. From routine food safety testing to advanced pharmacokinetic studies, the combination of immunoassays, chromatographic methods, and nanotechnology-based sensors allows researchers and regulators to measure residues at unprecedented sensitivity. Careful consideration of the matrix type, target concentration, and method capability is essential for accurate, reproducible results. As detection technology continues to evolve, the ability to uncover trace neomycin levels will become more accessible, reliable, and practical for real-world applications.
Chemiluminescence ELISA can detect as low as 9.4 µg/kg, while colorimetric methods using gold nanoparticles can achieve picomolar sensitivity with pre-treatment.
Yes, methods such as LC-MS/MS and capillary electrophoresis with laser-induced fluorescence are optimized for complex tissue matrices, enabling accurate measurement despite interference.
Nanomaterials amplify detection signals and increase surface interactions with neomycin molecules, achieving LODs in the nM or pM range.
Yes, pre-treatment like solid-phase extraction or immunoaffinity extraction is recommended to remove proteins, fats, and other interfering substances to achieve low LODs.
Lateral flow immunoassays offer simplicity, speed, and sufficient sensitivity for on-site screening, making them ideal for field use.
References
| Target | Cat. No. | Product Name | Host | Application | |
| NEO | HMABPY046 | RHA™ anti-Neomycin monoclonal antibody, clone NM | Mouse | ELISA, LFIA | Inquiry |
| DPABY-922 | Anti-Neomycin polyclonal antibody | Sheep | ELISA, Pr* | Inquiry | |
| DPAB-DC4563 | Anti-Neomycin polyclonal antibody | Sheep | EIA | Inquiry |
| Target | Cat. No. | Product Name | Conjugate | Application | |
| NEO | DAG1248 | Neomycin [HRP] | HRP | N/A | Inquiry |
| DAG4486 | Neomycin [KLH] | KLH | N/A | Inquiry | |
| DISNJ14 | Neomycin Sulfate Standard (98%) | N/A | ELISA | Inquiry | |
| DAGA-041B | Neomycin [BSA] | BSA | LFIA | Inquiry | |
| DAGA-033H | Neomycin [HRP] | HRP | ELISA | Inquiry | |
| DAG210S | Neomycin [HSA] | HSA | ELISA | Inquiry | |
| DAG500S | Neomycin [HSA-Biotin] | HSA-Biotin | ELISA | Inquiry | |
| DAG-WT391 | Neomycin [HSA] | HSA | Immunoassays | Inquiry | |
| DAGA-041O | Neomycin [OVA] | OVA | ELISA, LFIA | Inquiry |
| Target | Cat. No. | Product Name | Size | Species Reactivity | Application | Detection Sample | |
| NEO | DEIA-XY34 | Neomycin ELISA KIT | 96T | Human | Quantitative, Qualitative | biological samples | Inquiry |
| DEIA043 | Neomycin ELISA Kit | 96T | N/A | Quantitative | cell culture supernatant, vaccine, milk | Inquiry |
Loading ......
